Michel-Edwar Mickael
Overview
Explore the profile of Michel-Edwar Mickael including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lazarczyk M, Skiba D, Mickael M, Jaskula K, Nawrocka A, Religa P, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861181
Opioids are a challenging class of drugs due to their dual role. They alleviate pain, but also pose a risk of dependency, or trigger constipation, particularly in cancer patients, who...
2.
Mickael M, Kubick N, Atanasov A, Martinek P, Horbanczuk J, Floretes N, et al.
Curr Issues Mol Biol
. 2024 Aug;
46(8):8301-8319.
PMID: 39194707
The accurate identification of the primary tumor origin in metastatic cancer cases is crucial for guiding treatment decisions and improving patient outcomes. Copy number alterations (CNAs) and copy number variation...
3.
Sacharczuk M, Mickael M, Kubick N, Kaminska A, Horbanczuk J, Atanasov A, et al.
Curr Issues Mol Biol
. 2024 Aug;
46(8):7846-7861.
PMID: 39194682
Amyotrophic Lateral Sclerosis (ALS) is a poorly understood and fatal disease. It has a low prevalence and a 2-4 year survival period. Various theories and hypotheses relating to its development...
4.
Ruszczak A, Poznanski P, Lesniak A, Lazarczyk M, Skiba D, Nawrocka A, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 39000086
Currently, pharmacotherapy provides successful seizure control in around 70% of patients with epilepsy; however, around 30% of cases are still resistant to available treatment. Therefore, effective anti-epileptic therapy still remains...
5.
Mickael M, Kubick N, Dragan M, Atanasov A, Lawinski M, Paszkiewicz J, et al.
Immunol Res
. 2024 Jul;
72(5):883-894.
PMID: 38980567
No abstract available.
6.
Matin M, Matin F, Ksepka N, Wysocki K, Mickael M, Wieczorek M, et al.
Planta Med
. 2024 Jun;
90(11):834-843.
PMID: 38944033
Ginger () has a rich history of traditional medicinal use and has attracted a global interest in its health benefits. This study aims to provide insights into the clinical research...
7.
Litvinova O, Yeung A, Hammerle F, Mickael M, Matin M, Kletecka-Pulker M, et al.
Pharmaceuticals (Basel)
. 2024 Mar;
17(3).
PMID: 38543181
Adverse drug reactions continue to be not only one of the most urgent problems in clinical medicine, but also a social problem. The aim of this study was a bibliometric...
8.
Lazarczyk M, Kurzejamska E, Mickael M, Poznanski P, Skiba D, Sacharczuk M, et al.
Curr Issues Mol Biol
. 2023 May;
45(4):3446-3461.
PMID: 37185750
Colorectal cancer is the third most frequently diagnosed cancer in the world. Despite extensive studies and apparent progress in modern strategies for disease control, the treatment options are still not...
9.
Bhaumik S, Lazarczyk M, Kubick N, Klimovich P, Gurba A, Paszkiewicz J, et al.
Curr Issues Mol Biol
. 2023 Jan;
45(1):628-648.
PMID: 36661528
Regulatory T cell (Treg) suppression of conventional T cells is a central mechanism that ensures immune system homeostasis. The exact time point of Treg emergence is still disputed. Furthermore, the...
10.
Mickael M, Bienkowska I, Sacharczuk M
Genes (Basel)
. 2022 May;
13(5).
PMID: 35627275
The relationship between the evolutionary history and the differentiation of Bregs is still not clear. Bregs were demonstrated to possess a regulatory effect on B cells. Various subsets of Bregs...